What's breaking now, across thousands of outlets.
(MedPage Today) -- Adjuvant treatment with the mRNA-based cancer vaccine intismeran autogene plus pembrolizumab (Keytruda) significantly improved recurrence-free survival (RFS) in patients with resected stage IIB-IV melanoma, the phase III INTerpath...
We haven't written up this one. MedPage Today has the full story — the link below goes straight to it.
People with severe mental illness experienced more rapid increases in both weight and long-term blood sugar levels during the first three months after starting treatment with antipsychotic medication…
Researchers analyzed mulitomic and clinical data from 2000 colorectal cancer samples and used an AI tool, iPhenMap, to help identify cancer cell vulnerabilities and drug combinations that could be…
A first-of-its-kind cancer vaccine is significantly reducing the chances that melanoma patients' tumors come back, according to results of a major study released Thursday by drugmakers Moderna and…
'For seniors caught in these changes, the consequences could be significant, as many will have to find new coverage.'
Researchers developed an implantable, wirelessly powered electronic device, ECHO, that uses electrocatalysis to remove excess glucose from the bloodstream on demand, and could offer a drug-free…
As the ESMO conference kicks off, Tango's pancreatic cancer combination shows striking promise and detailed data on Moderna and Merck's cancer vaccine is released early.
